Roseola historical perspective: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(18 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Roseola}}
{{Roseola}}


{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{DAMI}}


==Overview==
==Overview==
For the first time, Zahorsky of St. Louis in 1910 described a febrile [[exanthem]] occurring in infants which he termed roseola. Human herpes virus 6 was first identified in 1986.


==Historical perspective==
==Historical Perspective==
*In 1986, Roseola virus was first isolated from patients who were diagnosed with HIV AIDS or a lymphoproliferative disorder from the peripheral blood leukocytes. <ref name="pmid2876520">{{cite journal| author=Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M et al.| title=Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. | journal=Science | year= 1986 | volume= 234 | issue= 4776 | pages= 596-601 | pmid=2876520 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2876520  }} </ref>
*For the first time, Zahorsky of St. Louis in 1910 described a febrile [[exanthem]] occurring in infants which he termed roseola.
*In 1986, Human herpes virus 6 (HHV6), the main causative agent of roseola disease was first isolated from patients who were diagnosed with [[HIV AIDS]] or a [[Lymphoproliferative disorders|lymphoproliferative disorder]] from the peripheral blood [[leukocytes]]. <ref name="pmid2876520">{{cite journal| author=Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M et al.| title=Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. | journal=Science | year= 1986 | volume= 234 | issue= 4776 | pages= 596-601 | pmid=2876520 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2876520  }} </ref>
* The two different variants of HHV 6 discovered by Frenkel, Ablashi and Aubin are variant A and Variant B HHV 6 strains.<ref name="pmid1648234">{{cite journal| author=Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N| title=Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. | journal=Proc Natl Acad Sci U S A | year= 1991 | volume= 88 | issue= 13 | pages= 5922-6 | pmid=1648234 | doi= | pmc=51990 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1648234  }} </ref><ref name="pmid1653487">{{cite journal| author=Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B et al.| title=Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. | journal=Virology | year= 1991 | volume= 184 | issue= 2 | pages= 545-52 | pmid=1653487 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1653487  }} </ref><ref name="pmid1848868">{{cite journal| author=Aubin JT, Collandre H, Candotti D, Ingrand D, Rouzioux C, Burgard M et al.| title=Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. | journal=J Clin Microbiol | year= 1991 | volume= 29 | issue= 2 | pages= 367-72 | pmid=1848868 | doi= | pmc=269769 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1848868  }} </ref>
*HHV 6A has been found to be more associated with the development of roseola.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Pediatrics]]
[[Category:Dermatology]]

Latest revision as of 00:03, 30 July 2020

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola historical perspective

CDC on Roseola historical perspective

Roseola historical perspective in the news

Blogs on Roseola historical perspective

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

For the first time, Zahorsky of St. Louis in 1910 described a febrile exanthem occurring in infants which he termed roseola. Human herpes virus 6 was first identified in 1986.

Historical Perspective

  • For the first time, Zahorsky of St. Louis in 1910 described a febrile exanthem occurring in infants which he termed roseola.
  • In 1986, Human herpes virus 6 (HHV6), the main causative agent of roseola disease was first isolated from patients who were diagnosed with HIV AIDS or a lymphoproliferative disorder from the peripheral blood leukocytes. [1]
  • The two different variants of HHV 6 discovered by Frenkel, Ablashi and Aubin are variant A and Variant B HHV 6 strains.[2][3][4]
  • HHV 6A has been found to be more associated with the development of roseola.

References

  1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M; et al. (1986). "Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders". Science. 234 (4776): 596–601. PMID 2876520.
  2. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N (1991). "Differentiation between two distinct classes of viruses now classified as human herpesvirus 6". Proc Natl Acad Sci U S A. 88 (13): 5922–6. PMC 51990. PMID 1648234.
  3. Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B; et al. (1991). "Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates". Virology. 184 (2): 545–52. PMID 1653487.
  4. Aubin JT, Collandre H, Candotti D, Ingrand D, Rouzioux C, Burgard M; et al. (1991). "Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction". J Clin Microbiol. 29 (2): 367–72. PMC 269769. PMID 1848868.